Kaleido Biosciences

$3.30 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Kaleido Biosciences

Kaleido Biosciences, Inc. operates as a biotechnology company. The Company focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. Kaleido Biosciences serves patients in the State of Massachusetts.

Stock Analysis

last close $3.45
1-mo return -24%
3-mo return -48.4%
avg daily vol. 129.87T
52-week high 20.5
52-week low 3.29
market cap. $170M
forward pe -
annual div. -
roe -276.6%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 81.8%
baraka

Subscribe now for daily local and international financial news

Subscribe